WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Cancer risk and overall survival in APC I1307K carriers. Results of a prospective phase II national study: Prophylactic radical fimbriectomy (NCT01608074), in women with a documented high risk of ...
Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and relative CVD risk in 76,600 patients with PC undergoing ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback